PE Tech Report


Like this article?

Sign up to our free newsletter

Piper Sandler holds final closing of Piper Heartland Healthcare Crossover Fund I

Piper Sandler Companies has held the final closing of the Piper Heartland Healthcare Crossover Fund USD, with over USD200 million in committed capital.

The Fund has already made seven investments deploying approximately USD40 million in capital.

The Fund is the first investment vehicle for Piper Heartland Healthcare Capital (Piper Heartland Healthcare), a dedicated healthcare investment platform within Piper Sandler, and will leverage the firm’s leading healthcare investment banking, capital markets and equity research capabilities. The Fund attracted premier investors from across the globe, including institutional investment firms, strategic investors, endowments and family offices.

Building on the industry knowledge and capital markets expertise of Piper Sandler’s leading healthcare banking and research platforms, the Fund will invest primarily in biotech, med-tech, and healthcare information sectors. The Fund will focus on innovative companies with near-term public markets prospects, driven by experienced management teams and backed by highly respected investment partners.

Like this article? Sign up to our free newsletter